Add Yahoo as a preferred source to see more of our stories on Google. Structure of a particle of HIV. The lab of a University of Utah biochemist laid the foundation for the development of a highly ...
Researchers at the Duke Human Vaccine Institute are one step closer to creating a vaccine for HIV, or human immunodeficiency virus, which can lead to AIDS (acquired immunodeficiency syndrome). "[In] ...
Gilead’s recently approved drug for HIV prevention, Yeztugo (lenacapavir), has the potential to transform the pre-exposure prophylaxis (PrEP) sector in the US, according to market analysts. The US ...
The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across the globe, including in areas where the PURPOSE trials were conducted. If ...
We know how to end new HIV transmissions in the United States. The science is here. We have PrEP to prevent HIV, and we know that for people living with HIV, maintaining an undetectable viral load ...
Ending the HIV epidemic is as urgent as ever. Scientific research has helped make tremendous progress in the last four decades, but every day, approximately 100 people in the U.S. and 3,500 worldwide ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results